BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 16, 2006
View Archived Issues
Valeant Gains Clearance For Parkinson's Adjunct, Zelapar
Two years after being labeled approvable by the FDA, Zelapar, a version of the Parkinson's disease drug selegiline designed using a fast-dissolving oral delivery system, finally was given the go-ahead to launch. (BioWorld Today)
Read More
Viropro Signs First Major Technology Transfer Deal
Read More
Pharma's Shopping Continues, With Focus On Antibody Firms
Read More
Santorum Voices Backing For Pluripotent Stem Cells
Read More
Other News To Note
Read More
Clinic Roundup
Read More